Proposal for Ketoprofen

---

Veterinary Drugs Directorate
Holland Cross Complex
Ground floor, Suite 14
11 Holland Avenue
Address Locator: 3000A
Ottawa, ON K1A OK9

File No: 9450-5-10

December 5, 2003

Dear Stakeholder:

The Veterinary Drugs Directorate (VDD) of Health Products and Food Branch, Health Canada is considering regulatory amendments which may be of interest to your organization. As the designated contact person of your organization, I would appreciate your collaboration in distributing this information to the attention of all interested parties in your organization to solicit their comments.

More specifically, the Veterinary Drugs Directorate is proposing to establish Maximum Residue Limits (MRLs) in Table III to Division 15, Part B of the Food and Drug Regulations for Ketoprofen in edible tissues of food producing animals and milk as indicated in the following table:

View Division 15, Part B of the Food and Drug Regulations for Ketoprofen in edible tissues of food producing animals and milk Table
(This will open in a new window with a file size of 4 K )
(You may have to use the scroll bar to see the entire table)

Ketoprofen , 2-(phenyl 3-benzoyl) propionic acid, is a non-steroidal anti-inflammatory agent (NSAID), belonging to the arylpropionic acid group. It is used in the treatment of inflammatory and painful conditions of the bones, joint and muscular-skeletal systems in cattle, horses, dogs and cats.

The result of our Health Risk Assessment shows that residues at the above noted concentrations will not pose any undue health risk for consumers. These proposed MRLs will be published in the Canada Gazette, Part I, after consideration of comments from stakeholders.

I would appreciate receiving your comments on this proposal by March 5, 2004. Comments should be sent to the attention of Dhurata Ikonomi, Public Involvement Officer, at the above noted address.

Thank you for your cooperation in this matter.

Yours sincerely,

Diane Kirkpatrick
Director General